An Oregon Health & Science University researcher has co-authored an international study that revealed a drug approved to prevent rejection in organ transplant patients helped treat a rare lung disease in women. The life-threatening disease has no cure ...
Researchers at Oregon Health & Science University’s Oregon National Primate Research Center may have good news for women at high-risk for ovarian cancer who also want to have children. The research suggests that a layer of cells, which serve as the ...
Researchers at Oregon Health & Science University’s School of Dentistry have discovered the underlying molecular mechanism behind the increase in production of a pain-signaling protein during inflammation, a project that used an animal model developed ...
Researchers at Oregon Health & Science University Doernbecher Children’s Hospital have identified a promising new approach to overcoming drug resistance in children with an extremely aggressive childhood muscle cancer known as alveolar ...
Martin Schreiber, M.D., of Oregon Health & Science University, received a research grant worth nearly $700,000 from the National Trauma Institute (NTI) to study a method that could more accurately determine how much blood-clot prevention medication to ...
Oregon Health & Science University’s Center for Coastal Margin Observation & Prediction (CMOP) has received a $17 million renewal grant from the National Science Foundation (NSF) Science and Technology Center to continue its research of coastal ...
The Sunday, February 20th issue of the New York Times featured information about obesity research conducted at the OHSU Oregon National Primate Research Center (ONPRC). Obesity is a serious problem in our country and around the world. The Centers for ...
Thanks to constantly evolving therapies, many women can now call themselves “former” cancer patients. However, for some of the tens of thousands of young women who fight and beat cancer each year, the same aggressive treatments that saved their lives ...
Brian J. Druker, M.D. — whose research led to the development of Gleevec, the first genetically targeted cancer drug that left healthy cells unharmed and revolutionized how the disease is treated — has received the prestigious Stanley J. Korsmeyer ...
Researchers at Oregon Health & Science University Doernbecher Children’s Hospital have defined the cell of origin for a kind of cancer called sarcoma. In a study published today as the Featured Article in the journal Cancer Cell, they report that ...